High expression levels of insulin-like growth factor-I receptor predict poor survival among women with clear-cell renal cell carcinomas

Alexander Parker, John C. Cheville, Carol A. Janney, James R Cerhan

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Currently, tumor stage and grade remain the only widely accepted prognostic indicators of clear-cell renal cell carcinoma (CC- RCC). As such, there is a need to identify other prognostic markers because behavior of CC-RCC cannot always be determined by stage alone. Recent studies of human CC-RCC cell lines suggest that insulin-like growth factor-I receptor (IGF-IR) may have some prognostic value for patients with CC-RCC. Using a population-based cohort of 48 female patients with CC-RCC and long-term follow-up, we tested the hypothesis that the immunohistochemical detection of IGF-IR expression in CC-RCC is associated with poorer cancer-specific survival after adjustment for stage and age at diagnosis. Kaplan-Meier analysis suggested that patients with CC-RCC that exhibited greater than 50% IGF-IR expression experienced a significantly poorer cancer-specific survival compared with patients with CC-RCC that exhibited less than 50% IGF-IR expression. The difference in survival was apparent at 2 years and remained throughout follow-up. Based on a Cox proportional hazard model that adjusted for stage and age at diagnosis, patients with tumors that exhibited greater than 50% IGF-IR staining were 4 times more likely to die of CC-RCC compared with patients whose tumors exhibited less than 50% staining (HR = 4.2; 95% confidence interval [CI]; 1.1-17.1). A smoothing spline with 4 degrees of freedom supported the results from the categorical analysis. Evidence from this population-based pilot investigation is consistent with laboratory data suggesting that expression of IGF-IR may have some prognostic implication for patients presenting with CC-RCC; however, confirmation in a larger study is needed.

Original languageEnglish (US)
Pages (from-to)801-805
Number of pages5
JournalHuman Pathology
Volume33
Issue number8
DOIs
StatePublished - Aug 2002

Fingerprint

IGF Type 1 Receptor
Renal Cell Carcinoma
Survival
Neoplasms
Staining and Labeling
Kaplan-Meier Estimate
Proportional Hazards Models
Population
Confidence Intervals
Cell Line

Keywords

  • Cohort studies
  • Insulin-like growth factor-I receptor
  • Renal cell carcinoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

High expression levels of insulin-like growth factor-I receptor predict poor survival among women with clear-cell renal cell carcinomas. / Parker, Alexander; Cheville, John C.; Janney, Carol A.; Cerhan, James R.

In: Human Pathology, Vol. 33, No. 8, 08.2002, p. 801-805.

Research output: Contribution to journalArticle

@article{dcc3a9cc4c5c48858ce4d50cce59ced4,
title = "High expression levels of insulin-like growth factor-I receptor predict poor survival among women with clear-cell renal cell carcinomas",
abstract = "Currently, tumor stage and grade remain the only widely accepted prognostic indicators of clear-cell renal cell carcinoma (CC- RCC). As such, there is a need to identify other prognostic markers because behavior of CC-RCC cannot always be determined by stage alone. Recent studies of human CC-RCC cell lines suggest that insulin-like growth factor-I receptor (IGF-IR) may have some prognostic value for patients with CC-RCC. Using a population-based cohort of 48 female patients with CC-RCC and long-term follow-up, we tested the hypothesis that the immunohistochemical detection of IGF-IR expression in CC-RCC is associated with poorer cancer-specific survival after adjustment for stage and age at diagnosis. Kaplan-Meier analysis suggested that patients with CC-RCC that exhibited greater than 50{\%} IGF-IR expression experienced a significantly poorer cancer-specific survival compared with patients with CC-RCC that exhibited less than 50{\%} IGF-IR expression. The difference in survival was apparent at 2 years and remained throughout follow-up. Based on a Cox proportional hazard model that adjusted for stage and age at diagnosis, patients with tumors that exhibited greater than 50{\%} IGF-IR staining were 4 times more likely to die of CC-RCC compared with patients whose tumors exhibited less than 50{\%} staining (HR = 4.2; 95{\%} confidence interval [CI]; 1.1-17.1). A smoothing spline with 4 degrees of freedom supported the results from the categorical analysis. Evidence from this population-based pilot investigation is consistent with laboratory data suggesting that expression of IGF-IR may have some prognostic implication for patients presenting with CC-RCC; however, confirmation in a larger study is needed.",
keywords = "Cohort studies, Insulin-like growth factor-I receptor, Renal cell carcinoma",
author = "Alexander Parker and Cheville, {John C.} and Janney, {Carol A.} and Cerhan, {James R}",
year = "2002",
month = "8",
doi = "10.1053/hupa.2002.126186",
language = "English (US)",
volume = "33",
pages = "801--805",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "8",

}

TY - JOUR

T1 - High expression levels of insulin-like growth factor-I receptor predict poor survival among women with clear-cell renal cell carcinomas

AU - Parker, Alexander

AU - Cheville, John C.

AU - Janney, Carol A.

AU - Cerhan, James R

PY - 2002/8

Y1 - 2002/8

N2 - Currently, tumor stage and grade remain the only widely accepted prognostic indicators of clear-cell renal cell carcinoma (CC- RCC). As such, there is a need to identify other prognostic markers because behavior of CC-RCC cannot always be determined by stage alone. Recent studies of human CC-RCC cell lines suggest that insulin-like growth factor-I receptor (IGF-IR) may have some prognostic value for patients with CC-RCC. Using a population-based cohort of 48 female patients with CC-RCC and long-term follow-up, we tested the hypothesis that the immunohistochemical detection of IGF-IR expression in CC-RCC is associated with poorer cancer-specific survival after adjustment for stage and age at diagnosis. Kaplan-Meier analysis suggested that patients with CC-RCC that exhibited greater than 50% IGF-IR expression experienced a significantly poorer cancer-specific survival compared with patients with CC-RCC that exhibited less than 50% IGF-IR expression. The difference in survival was apparent at 2 years and remained throughout follow-up. Based on a Cox proportional hazard model that adjusted for stage and age at diagnosis, patients with tumors that exhibited greater than 50% IGF-IR staining were 4 times more likely to die of CC-RCC compared with patients whose tumors exhibited less than 50% staining (HR = 4.2; 95% confidence interval [CI]; 1.1-17.1). A smoothing spline with 4 degrees of freedom supported the results from the categorical analysis. Evidence from this population-based pilot investigation is consistent with laboratory data suggesting that expression of IGF-IR may have some prognostic implication for patients presenting with CC-RCC; however, confirmation in a larger study is needed.

AB - Currently, tumor stage and grade remain the only widely accepted prognostic indicators of clear-cell renal cell carcinoma (CC- RCC). As such, there is a need to identify other prognostic markers because behavior of CC-RCC cannot always be determined by stage alone. Recent studies of human CC-RCC cell lines suggest that insulin-like growth factor-I receptor (IGF-IR) may have some prognostic value for patients with CC-RCC. Using a population-based cohort of 48 female patients with CC-RCC and long-term follow-up, we tested the hypothesis that the immunohistochemical detection of IGF-IR expression in CC-RCC is associated with poorer cancer-specific survival after adjustment for stage and age at diagnosis. Kaplan-Meier analysis suggested that patients with CC-RCC that exhibited greater than 50% IGF-IR expression experienced a significantly poorer cancer-specific survival compared with patients with CC-RCC that exhibited less than 50% IGF-IR expression. The difference in survival was apparent at 2 years and remained throughout follow-up. Based on a Cox proportional hazard model that adjusted for stage and age at diagnosis, patients with tumors that exhibited greater than 50% IGF-IR staining were 4 times more likely to die of CC-RCC compared with patients whose tumors exhibited less than 50% staining (HR = 4.2; 95% confidence interval [CI]; 1.1-17.1). A smoothing spline with 4 degrees of freedom supported the results from the categorical analysis. Evidence from this population-based pilot investigation is consistent with laboratory data suggesting that expression of IGF-IR may have some prognostic implication for patients presenting with CC-RCC; however, confirmation in a larger study is needed.

KW - Cohort studies

KW - Insulin-like growth factor-I receptor

KW - Renal cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=0036692208&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036692208&partnerID=8YFLogxK

U2 - 10.1053/hupa.2002.126186

DO - 10.1053/hupa.2002.126186

M3 - Article

C2 - 12203212

AN - SCOPUS:0036692208

VL - 33

SP - 801

EP - 805

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 8

ER -